Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice

European Journal of Pharmacology

Volumn 658, Issue 1, 2011, Pages 28-40

  Mondello, Stefania ^a   Galuppo, Maria ^b   Mazzon, Emanuela ^c   Italiano, Domenico ^c   Mondello, Patrizia ^a   Aloisi, Carmela ^a   Cuzzocrea, Salvatore ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

Apoptosis; Cytokine; Glutamine; Inflammation; Zymosan induced multiple organ failure

Indexed keywords

3 NITROTYROSINE; FAS LIGAND; GLUTAMINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MECHANISM; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; INTESTINE INJURY; KIDNEY DYSFUNCTION; LIPID PEROXIDATION; LIVER INJURY; LUNG INJURY; MALE; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PANCREAS INJURY; PERITONEUM EXUDATE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WEIGHT REDUCTION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BODY WEIGHT; CYTOKINES; ENZYME ACTIVATION; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION; GLUTAMINE; INFLAMMATION; LIPID PEROXIDATION; MALE; MICE; MULTIPLE ORGAN FAILURE; NEUTROPHIL INFILTRATION; NITRIC OXIDE; PERITONEAL CAVITY; POLY ADENOSINE DIPHOSPHATE RIBOSE; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-BCL-2; TYROSINE; ZYMOSAN;

EID: 79952819111     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.02.008     Document Type: Article

References (38)

1. M. Abdelrahman, E.J. Sharples, M.C. McDonald, M. Collin, N.S. Patel, M.M. Yaqoob, and C. Thiemermann Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia Shock 22 2004 63 69 (Pubitemid 40228212)
2. K. Ban, and R.A. Kozar Enteral glutamine: a novel mediator of PPARgamma in the postischemic gut J Leukoc Biol 84 2008 595 599
3. A.E. Baue, R. Durham, and E. Faist Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 10 1998 79 89 (Pubitemid 128463838)
4. R.C. Bone, R.A. Balk, F.B. Cerra, R.P. Dellinger, A.M. Fein, W.A. Knaus, R.M. Schein, and W.J. Sibbald Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis The ACCP/SCCM Consensus Conference Committee Chest 136 2009 American College of Chest Physicians/Society of Critical Care Medicine e28 1992
5. C.G. Cochrane Mechanisms of oxidant injury of cells Mol Aspects Med 12 1991 137 147
6. R. Curi, C.J. Lagranha, S.Q. Doi, D.F. Sellitti, J. Procopio, T.C. Pithon-Curi, M. Corless, and P. Newsholme Molecular mechanisms of glutamine action J Cell Physiol 204 2005 392 401 (Pubitemid 40934632)
7. S. Cuzzocrea, G. de Sarro, G. Costantino, E. Mazzon, R. Laura, E. Ciriaco, A. de Sarro, and A.P. Caputi Role of interleukin-6 in a non-septic shock model induced by zymosan Eur Cytokine Netw 10 1999 191 203 (Pubitemid 29332775)
8. S. Cuzzocrea, F. Imperatore, G. Costantino, C. Luongo, E. Mazzon, M.A. Scafuro, G. Mangoni, A.P. Caputi, F. Rossi, and A. Filippelli Role of hyperbaric oxygen exposure in reduction of lipid peroxidation and in multiple organ failure induced by zymosan administration in the rat Shock 13 2000 197 203
9. S. Cuzzocrea, E. Mazzon, R. Di Paola, N.S. Patel, T. Genovese, C. Muia, A. De Sarro, and C. Thiemermann Erythropoietin reduces the development of experimental inflammatory bowel disease J Pharmacol Exp Ther 311 2004 1272 1280 (Pubitemid 39612737)
10. S. Cuzzocrea, E. Mazzon, L. Dugo, A. Barbera, T. Centorrino, A. Ciccolo, M.T. Fonti, and A.P. Caputi Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan Shock 16 2001 51 58 (Pubitemid 33598188)
11. S. Cuzzocrea, A. Rossi, I. Serraino, R. Di Paola, L. Dugo, T. Genovese, D. Britti, G. Sciarra, A. De Sarro, A.P. Caputi, and L. Sautebin Role of 5-lipoxygenase in the multiple organ failure induced by zymosan Intensive Care Med 30 2004 1935 1943 (Pubitemid 39468416)
12. J. Damas, G. Remacle-Volon, and V. Bourdon Platelet-activating factor and the vascular effects of zymosan in rats Eur J Pharmacol 231 1993 231 236 (Pubitemid 23050905)
13. E.A. Deitch Role of the gut lymphatic system in multiple organ failure Curr Opin Crit Care 7 2001 92 98 (Pubitemid 32411397)
14. E.A. Deitch, W.J. Ma, L. Ma, R.D. Berg, and R.D. Specian Protein malnutrition predisposes to inflammatory-induced gut-origin septic states Ann Surg 211 1990 560 568 (Pubitemid 20155694)
15. A. Demirkan, B. Savas, and M. Melli Endotoxin level in ischemia-reperfusion injury in rats: effect of glutamine pretreatment on endotoxin levels and gut morphology Nutrition 26 2010 106 111
16. R. Demling, U. Nayak, K. Ikegami, and C. LaLonde Comparison between lung and liver lipid peroxidation and mortality after zymosan peritonitis in the rat Shock 2 1994 222 227
17. L. Dugo, P.K. Chatterjee, E. Mazzon, M.C. McDonald, R.D. Paola, F. Fulia, A.P. Caputi, C. Thiemermann, and S. Cuzzocrea The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat Intensive Care Med 28 2002 775 788 (Pubitemid 34639493)
18. J.P. Eiserich, M. Hristova, C.E. Cross, A.D. Jones, B.A. Freeman, B. Halliwell, and A. van der Vliet Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils Nature 391 1998 393 397 (Pubitemid 28093514)
19. R.J. Goris, I.P. van Bebber, R.M. Mollen, and J.P. Koopman Does selective decontamination of the gastrointestinal tract prevent multiple organ failure? An experimental study Arch Surg 126 1991 561 565
20. T.R. Harward, D. Coe, W.W. Souba, N. Klingman, and J.M. Seeger Glutamine preserves gut glutathione levels during intestinal ischemia/reperfusion J Surg Res 56 1994 351 355 (Pubitemid 24129876)
21. H.M. Ko, S.H. Oh, H.S. Bang, N.I. Kang, B.H. Cho, S.Y. Im, and H.K. Lee Glutamine protects mice from lethal endotoxic shock via a rapid induction of MAPK phosphatase-1 J Immunol 182 2009 7957 7962
22. J.M. Lacey, and D.W. Wilmore Is glutamine a conditionally essential amino acid? Nutr Rev 48 1990 297 309
23. H. Lochs, C. Dejong, F. Hammarqvist, X. Hebuterne, M. Leon-Sanz, T. Schutz, W. van Gemert, A. van Gossum, L. Valentini, H. Lubke, S. Bischoff, N. Engelmann, and P. Thul ESPEN guidelines on enteral nutrition: gastroenterology Clin Nutr 25 2006 260 274 (Pubitemid 43811680)
24. J. Mahesh, J. Daly, W.G. Cheadle, and G.J. Kotwal Elucidation of the early events contributing to zymosan-induced multiple organ dysfunction syndrome using MIP-1alpha, C3 knockout, and C5-deficient mice Shock 12 1999 340 349
25. S. Mondello, M. Galuppo, E. Mazzon, I. Domenico, P. Mondello, A. Carmela, and S. Cuzzocrea Glutamine treatment attenuates the development of ischaemia/reperfusion injury of the gut Eur J Pharmacol 643 2010 304 315
26. K.M. Mullane, W. Westlin, and R. Kraemer Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischemia and reperfusion Ann NY Acad Sci 524 1988 103 121
27. S. Ohkawa, M. Sugiura, and R. Okada An aged case of trifascicular block with special reference to a histological study of the conduction system Jpn Heart J 15 1974 314 321
28. Z.N. Oltvai, C.L. Milliman, and S.J. Korsmeyer Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death Cell 74 1993 609 619 (Pubitemid 23259742)
29. F. Petit, G.J. Bagby, and C.H. Lang Tumor necrosis factor mediates zymosan-induced increase in glucose flux and insulin resistance Am J Physiol 268 1995 219 228
30. J.T. Prem, M. Eppinger, G. Lemmon, S. Miller, D. Nolan, and J. Peoples The role of glutamine in skeletal muscle ischemia/reperfusion injury in the rat hind limb model Am J Surg 178 1999 147 150 (Pubitemid 29412957)
31. F.L. Scott, B. Stec, C. Pop, M.K. Dobaczewska, J.J. Lee, E. Monosov, H. Robinson, G.S. Salvesen, R. Schwarzenbacher, and S.J. Riedl The Fas-FADD death domain complex structure unravels signalling by receptor clustering Nature 457 2008 1019 1022
32. K. Sharma, R.X. Wang, L.Y. Zhang, D.L. Yin, X.Y. Luo, J.C. Solomon, R.F. Jiang, K. Markos, W. Davidson, D.W. Scott, and Y.F. Shi Death the Fas way: regulation and pathophysiology of CD95 and its ligand Pharmacol Ther 88 2000 333 347 (Pubitemid 32406057)
33. C. Szabo, L.H. Lim, S. Cuzzocrea, S.J. Getting, B. Zingarelli, R.J. Flower, A.L. Salzman, and M. Perretti Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects J Exp Med 186 1997 1041 1049 (Pubitemid 27441148)
34. C. Szabo, B. Zingarelli, M. O'Connor, and A.L. Salzman DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite Proc Natl Acad Sci USA 93 1996 1753 1758 (Pubitemid 26079829)
35. I.P. van Bebber, W.K. Boekholz, R.J. Goris, P.H. Schillings, H.P. Dinges, S. Bahrami, H. Redl, and G. Schlag Neutrophil function and lipid peroxidation in a rat model of multiple organ failure J Surg Res 47 1989 471 475 (Pubitemid 20012046)
36. T.J. Volman, R.J. Goris, M. van der Jagt, F.A. van de Loo, and T. Hendriks Organ damage in zymosan-induced multiple organ dysfunction syndrome in mice is not mediated by inducible nitric oxide synthase Crit Care Med 30 2002 1553 1559 (Pubitemid 34756240)
37. E.J. von Asmuth, J.G. Maessen, C.J. van der Linden, and W.A. Buurman Tumour necrosis factor alpha (TNF-alpha) and interleukin 6 in a zymosan-induced shock model Scand J Immunol 32 1990 313 319 (Pubitemid 20332708)
38. P.E. Wischmeyer, D. Jayakar, U. Williams, K.D. Singleton, J. Riehm, E.A. Bacha, V. Jeevanandam, U. Christians, and N. Serkova Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia-reperfusion injury JPEN J Parenter Enteral Nutr 27 2003 396 403 (Pubitemid 38133103)